Skip to main content

Table 1 The demographic data of included cases

From: Vaccine-associated complications: a comparative multicenter evaluation among dental practitioners and dental students—which candidate vaccine is more safe in SARS COV II, Gam-COVID-Vac (Sputnik V), ChAdOx1 nCoV-19 (AstraZeneca), BBV152 (Covaxin), or BBIBP-CorV(Sinopharm)?

  Number Percent
Gender (female) 681 60.2%
Occupation
Dental student 104 9.2%
Postgraduate dental student 178 15.7%
General dentist 831 73.4%
Professional dentist 19 1.7%
History of coronavirus infections 269 23.8%
Infected once 245 21.6%
Infected more than once 24 2.2%
History of previous viral infections
Influenza 318 28.1%
MERS, 1 0.1%
EBV (mononucleosis) 17 1.5%
None 796 70.3%
Type of administered vaccine
ChAdOx1 nCoV-19 578 51.1%
Gam-COVID-Vac 426 37.6%
BBV152 25 2.2%
BBIBP-CorV 102 9.0%
Onset of vaccine side effects:
0–12 h 499 44.1%
12–24 h 328 29.0%
1–2 d 96 8.5%
3–4 d 19 1.7%
5–7 d 9 0.8%
1–2 w 12 1.1%
3–4 w 3 0.3%
No side effect 166 14.7%
How long after vaccine that you have side effects (duration of side effects)
Few hours 191 16.9%
1 d 498 44.0%
1–3 d 358 31.6%
3–7 d 48 4.2%
7–14 d 10 0.9%
>14 d 4 0.4%
None 23 2.0%
  1. Abbreviations: h hour, d day, w week